|
Market Closed -
Other stock markets
|
After hours 17:33:09 | |||
| 23.60 EUR | -1.46% |
|
23.62 | +0.11% |
| 02-11 | Formycon, Lotus Sign License Deal for Keytruda Biosimilar in Asia-Pacific Region | MT |
| 02-11 | Swiss stocks - Factors to watch on February 11 | RE |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FORMYCON AG | Other Biotechnology & Medical Research | -1.46% | +2.39% | -7.81% | -54.70% | -66.09% | 502M |  |  | |
- Stock Market
- Equities
- FYB Stock
- Charts Formycon AG
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition